- Home
- ZS vs WAT Comparison
ZS vs WAT Comparison
Compare ZS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- WAT
- Stock Information
- Founded
- ZS 2007
- WAT 1958
- Country
- ZS United States
- WAT United States
- Employees
- ZS N/A
- WAT N/A
- Industry
- ZS EDP Services
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ZS Technology
- WAT Industrials
- Exchange
- ZS Nasdaq
- WAT Nasdaq
- Market Cap
- ZS 31.7B
- WAT 22.5B
- IPO Year
- ZS 2018
- WAT 1995
- Fundamental
- Price
- ZS $206.36
- WAT $382.52
- Analyst Decision
- ZS Buy
- WAT Hold
- Analyst Count
- ZS 35
- WAT 13
- Target Price
- ZS $226.21
- WAT $363.92
- AVG Volume (30 Days)
- ZS 2.2M
- WAT 531.4K
- Earning Date
- ZS 12-02-2024
- WAT 02-04-2025
- Dividend Yield
- ZS N/A
- WAT N/A
- EPS Growth
- ZS N/A
- WAT N/A
- EPS
- ZS N/A
- WAT 10.48
- Revenue
- ZS $2,299,023,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- ZS $24.23
- WAT $0.53
- Revenue Next Year
- ZS $20.79
- WAT $5.59
- P/E Ratio
- ZS N/A
- WAT $36.68
- Revenue Growth
- ZS 30.77
- WAT N/A
- 52 Week Low
- ZS $153.45
- WAT $279.24
- 52 Week High
- ZS $259.61
- WAT $397.02
- Technical
- Relative Strength Index (RSI)
- ZS 53.68
- WAT 54.08
- Support Level
- ZS $200.15
- WAT $380.60
- Resistance Level
- ZS $216.70
- WAT $397.02
- Average True Range (ATR)
- ZS 7.24
- WAT 9.73
- MACD
- ZS -0.87
- WAT -0.60
- Stochastic Oscillator
- ZS 53.13
- WAT 53.47
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.